Tradestie Institutional Equity Comparison Engine

LFCR vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Growth & Margin, Momentum & Technical while LFCR counters with relative strength in Valuation, Options & Structure. Fundamentally, LFCR trades at 8.7x Forward P/E with -6.2% operating margin (-18.6% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, LFCR sits in CONSOLIDATION (<1st %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LFCR
LFCR 8.7x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner AVDL
Op Margin -6.2% vs 2.5% ยท YoY -18.6% vs +54.9%
Momentum & Technical Winner AVDL
1Y -14.7% vs +138.1% ยท 52W Pos 52% vs 89%
Options & Structure Winner LFCR
CONSOLIDATION (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
LFCR NASDAQ
Lifecore Biomedical, Inc. Common Stock
Pharmaceutical Preparations
$6.39
+0.31% 1D
Market Cap $241.5M
1M Return +0.31%
1Y Return -14.69%
Forward P/E 8.7x
Unified AI Score
58.2 / 100 HOLD
Tech 52.0 Fund 55.0 Flow 62.0 Mom 50.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LFCR -14.69% AVDL +138.06% Spread: +2.85 pp (LFCR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LFCR TTM Op. Margin: -6.2% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LFCR vs AVDL. Trailing 12-month operating profitability (LFCR -6.2% vs AVDL 2.5%) and valuation multiples (LFCR 8.7x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LFCR (2) vs AVDL (8)
Institutional Metric LFCR AVDL Criterion Row Winner
Market Capitalization Scale $241.5M $2.1B Larger Scale AVDL
Trailing P/E Ratio Valuation 8.7x 16.8x Lower Multiple LFCR
Forward P/E Ratio Valuation 8.7x 28.8x Lower Multiple LFCR
Revenue Growth (YoY) Growth -18.6% +54.9% Higher Growth AVDL
Operating Margin (TTM) Profitability -6.2% 2.5% Higher Margin AVDL
Net Profit Margin Profitability -66.8% -0.1% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency -76.4% -0.3% Higher ROE AVDL
52-Week Range Position Momentum 52% ($4โ€“$9) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 9% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LFCR vs AVDL Buy Guide
LFCR CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live LFCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LFCR nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.